Blog

Endometriosis: Complete Guide with BSA Pharma Gynacare Division Support

Overview

  • Definition: Endometriosis is a chronic condition where tissue similar to the uterine lining grows outside the uterus, causing pain, inflammation, and fertility issues.

  • Key Facts:

    • Affects 1 in 10 women of reproductive age worldwide (approx. 190 million)

    • Commonly diagnosed in women aged 20–40 years.

  • Target Audience: Women of reproductive age, healthcare providers, and caregivers seeking reliable treatment and management options.

 

 

Causes and Risk Factors

  • Biological Causes:

    • Retrograde menstruation (blood flows back into pelvic cavity).

    • Immune system dysfunction.

  • Lifestyle/Environmental Factors:

    • Early menarche, late menopause.

    • High estrogen levels, low BMI.

  • High‑Risk Groups:

    • Women with family history of endometriosis.

    • Those with short cycles (<27 days) or heavy bleeding.

 

 

Symptoms and Diagnosis

  • Common Symptoms:

    • Severe pelvic pain, painful periods (dysmenorrhea).

    • Pain during intercourse, urination, or bowel movements.

    • Heavy menstrual bleeding, infertility, fatigue, bloating.

  • Diagnostic Methods:

    • Pelvic exam, ultrasound, MRI.

    • Definitive diagnosis via laparoscopy with biopsy.

    • Importance of Early Detection: Prevents progression, reduces fertility complications, and improves quality of life.

 

 

Treatment Options

Standard Medical Treatments

  • Pain management: NSAIDs (ibuprofen, naproxen).

  • Hormonal therapy: Birth control pills, progestins, GnRH analogues.

  • Surgical options: Laparoscopic removal of lesions, hysterectomy in severe cases.

Lifestyle Modifications

  • Balanced diet rich in omega‑3 fatty acids.

  • Stress management, yoga, physiotherapy.

  • Support groups for emotional well‑being.

BSA Pharma Inc’s Gynacare Division

  • Mechanism of Action: Products regulate hormones, reduce inflammation, and support reproductive health.

  • Highlighted Products:

    • DUBENDO‑10 (Dydrogesterone 10mg): Hormonal support for menstrual regulation.

    • UTRIBIS‑200/300 SR (Progesterone sustained release): Supports uterine health and fertility.

    • BARJANA‑D (Ethinylestradiol + Dienogest): Hormonal therapy for endometriosis management.

    • FIBROCYST Tab (Ayurvedic): Herbal support for fibroids, cysts, and PCOS.

  • Benefits: Hormonal balance, pain relief, improved fertility outcomes.

  • Usage Guidelines: Always under physician supervision.

  • Compliance & Safety Notes: Avoid self‑medication; monitor side effects; consult gynecologist regularly.

 

 

Prevention and Management

  • Preventive Strategies:

    • Early awareness of symptoms.

    • Regular gynecological check‑ups.

  • Long‑Term Care:

    • Combination of medical therapy, lifestyle changes, and supportive supplements.

  • Role of Gynacare Division Products:

    • Hormonal therapies (DUBENDO, UTRIBIS).

    • Nutritional supplements (FER‑Q Forte, CALBO‑M).

    • Herbal tonics (UTRIBIS Syrup, FIBROCYST Tab) for holistic support.

 

 

FAQs

Q1: Can endometriosis be cured?
 No, but symptoms can be managed effectively with medication, surgery, and supportive products.

Q2: Do Gynacare Division products replace medical treatment?
 No, they complement standard therapies under medical supervision.

Q3: Can endometriosis affect fertility?
 Yes, it can cause scarring and blockages, but treatments like progesterone therapy and IVF improve outcomes.

Q4: Are herbal products safe for endometriosis?
 Herbal formulations like FIBROCYST Tab may support symptom relief, but medical consultation is essential.

 

 

References

 

Related Posts